Results 21 to 30 of about 1,199,246 (381)

Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review

open access: yesJournal of Clinical Medicine, 2020
Interstitial lung disease (ILD) is one of the most serious pulmonary complications of connective tissue diseases (CTDs) and it is characterized by a deep impact on morbidity and mortality. Due to the poor knowledge of CTD-ILD’s natural history and due to
C. Vacchi   +6 more
semanticscholar   +1 more source

Pulmonary hypertension in connective tissue diseases, new evidence and challenges

open access: yesEuropean Journal of Clinical Investigation, 2020
Pulmonary arterial hypertension is a lethal complication of different connective tissue diseases such as systemic sclerosis, mixed connective tissue disease and systemic lupus erythematosus.
M. Vonk   +2 more
semanticscholar   +1 more source

Effect of Nigella sativa oil extracts on inflammatory and oxidative stress markers in Behcet’s disease: A randomized, double-blind, placebo-controlled clinical trial [PDF]

open access: yesAvicenna Journal of Phytomedicine, 2020
Objective: Behcet's disease (BD) is a chronic inflammatory disorder characterized by recurrent oral and genital aphthous ulcers, uveitis and skin lesions. Oxidative stress and inflammation have important role in the pathogenesis of BD.
Shahrzad Amizadeh   +7 more
doaj   +1 more source

Psoriasis and Connective Tissue Diseases

open access: yesInternational Journal of Molecular Sciences, 2020
Psoriasis is a chronic systemic inflammatory disease with various co-morbidities, having been recently considered as a comprehensive disease named psoriatic disease or psoriatic syndrome. Autoimmune diseases are one form of its co-morbidities.
Toshiyuki Yamamoto
semanticscholar   +1 more source

Comparison of International Study Group Criteria and International Criteria for Behcet's Disease in the Azeri population of Iran [PDF]

open access: yesJournal of Analytical Research in Clinical Medicine, 2017
Introduction: Behcet's disease (BD) is a chronic systemic inflammatory disease affecting multiple organs and systems such as mucosa, skin, eye, joints and cardiovascular, nervous and gastrointestinal systems. Various criteria are proposed for
Leila Delnabi   +4 more
doaj   +1 more source

Disorders of the Aorta and Aortic Valve in Connective Tissue Diseases

open access: yesCurrent Cardiology Reports, 2020
Purpose of Review The incidence of aortic valve disease in inherited connective tissue disorders is well documented; however, recent studies have only begun to unravel the pathology behind this association. In this review, we aim to describe the etiology,
B. Grygiel-Górniak   +3 more
semanticscholar   +1 more source

Efficacy of Nigella sativa seeds oil in patients with Behcet’s disease: a double-blind randomized controlled trial [PDF]

open access: yesAvicenna Journal of Phytomedicine, 2018
Objective: Nigella sativa (NS) is a herbal medicine with anti-inflammatory and anti-oxidant functions. This study was designed to evaluate the effect of oral administration of NS seeds oil on the treatment of Behcet’s disease (BD).
Hadiseh Kavandi   +2 more
doaj   +1 more source

Pain in systemic connective tissue diseases [PDF]

open access: yes, 2015
Pain is frequent in patients with connective tissue diseases (CTDs), particularly those affected by systemic sclerosis (SSc) and systemic lupus erythematosus (SLE) in which it is virtually ubiquitous and can have different causes.
Atzeni, Fabiola   +4 more
core   +1 more source

Prevalence of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review of the literature [PDF]

open access: yes, 2013
Pulmonary arterial hypertension (PAH) is a progressive and life-threatening disease. Understanding of PAH prevalence remains limited, but PAH has been reported as a frequent complication in connective tissue diseases.
Jack Mardekian   +4 more
core   +1 more source

Exploring metabolism in scleroderma reveals opportunities for pharmacological intervention for therapy in fibrosis

open access: yesFrontiers in Immunology, 2022
BackgroundRecent evidence has indicated that alterations in energy metabolism play a critical role in the pathogenesis of fibrotic diseases. Studies have suggested that ‘metabolic reprogramming’ involving the glycolysis and oxidative phosphorylation ...
Isabella Gomes Cantanhede   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy